Mediaboss Marketing

Progressive jackpot slots open the door for a life-changing win, like the Mega Moolah jackpot that fetched 13.2 million to a British soldier Jon Heywood from the UK in October 2015.

If you wondered how the best slot casino sites cover such a big amount of money, the answer is they dont.

Its managed by software providers. When you play a slot game, developers take a small percentage of your bet to form the progressive jackpot. Depending upon the popularity and number of players in the game, it grows. Whether you play live or on an online casino, the prize pool rises with time until someone gets lucky and hits it.

So, all you have to do is try your luck at some of the best UK slot sites if you want to win big.

Microgamings Mega Moolah is also widely known by the name Millionaire-Maker.

Many games contribute to its accumulated pools of the jackpot like Mega Moolah, Mega Moolah Isis, Mega Moolah 5-Reel Drive, and Mega Moolah Summertime. It has 5-reels and a total of 25 adjustable paylines. You benefit from 15 free spins with 3x multipliers, wild, and scatter symbols.

Software developer Playtech manages it. It has 50 paylines spread across 5-reels, and you benefit from stacked wild cards, scatters, and jackpot giant bonus offers.

It is a part of the Marvel Mystery Jackpot series developed by Playtech. It employs 5-reels and has 25 adjustable paylines. You benefit from a range of special features, including the Smash Bonus game and up to 10 free spins. Its jackpot is linked to four different progressive prizes the Power, Extra Power, Super Power, and Ultimate Power jackpots.

Leading software developer NetEnt developed the game Arabian Nights the first-rate progressive slots. It takes you to an exotic Arabian world full of hidden treasures and offers slots in 10 adjustable paylines, spread across 5-reels. You benefit from scatter symbols that unlock up to 15 free spins and a wild symbol that lands you either the progressive prize or a consolation prize of up to 10,000 coins.

Developed by IGT, the game offers you a chance to walk away with a life-changing progressive jackpot. It has standard 5-reels with 20 adjustable payline, but the game allows re-triggering of free spins that let you win up to 180 spins. The jackpot gets triggered when five Mega Jackpots symbols positions on the centre payline.

Its a luxury theme slot game developed by BetSoft that aims at preparing players for three progressive prizes the Big, the Huge, and the Mega jackpots. It has 20 adjustable paylines across 5-reels, and you benefit from 16 free spins, bonus symbols, and a wild triggering a re-spin.

Software providers like Microgaming, Playtech, NetEnt, BetSoft, and IGT are some of the most respected developers to create the biggest progressive slots rewards in the gambling world.

Remember, its all luck, and you have an equal chance of winning the jackpot by playing at 25p per spin, as you do at maximum stakes!

Read the rest here:
WANT TO WIN BIG? TRY THESE PROGRESSIVE JACKPOT SLOTS GAMES - Island Echo

REDDING, Calif., March 22, 2021 /PRNewswire/ -- Infectious disease diagnostic products comprise consumables, instruments, software & services used for the diagnosis of infectious diseases, such as influenza, tuberculosis, hepatitis, and others. Infectious disease diagnostics is an emerging market as it helps doctors and clinicians in early diagnosis, thereby offering appropriate treatment. Owing to the recent outbreak of coronavirus (COVID-19), this market is expected to expand in the upcoming years as more and more diagnostic test kits will be required for early diagnosis.

The infectious disease diagnostics market is expected to grow at a CAGR of 6.9% from 2020 to reach $42.85 billion by 2027. The growth of this market is mainly attributed to the increasing prevalence of infectious diseases, growing awareness for early disease diagnoses, increasing funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing. Moreover, the outbreak of the COVID19 pandemic will result in higher demand for infectious disease diagnostic products.

DownloadFree Sample Report Now @https://www.meticulousresearch.com/download-sample-report/cp_id=4976

The global infectious disease diagnostics market is segmented on the basis of product & service, technology, disease type, end user, and geography.

Based on product & service, the infectious disease diagnostics market is segmented into consumables, instruments, and software & services. In 2020, the consumables segment accounted for the largest share of the overall infectious disease diagnostics market. The large share of this segment is primarily attributed to the commercial availability of a diverse range of reagents & consumables for various diseases diagnosis and their recurrent expense. In addition, the outbreak of COVID-19 is expected to accelerate the growth of this segment, owing to the requirement of various kits and assays.

Based on technology, the infectious disease diagnostics market is broadly segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing & next-generation sequencing (NGS), DNA microarray, and other technologies (microscopy, hybridization, and loop-mediated isothermal amplification). In 2020, the immunodiagnostics segment accounted for the largest share of the overall infectious disease diagnostics market. The large share of this segment is primarily attributed to the emergence of advanced diagnostic immunoassay formats, increasing usage of miniaturized devices, and rising trend for automation in immunoassay instruments.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business:https://www.meticulousresearch.com/speak-to-analyst/cp_id=4976

Based on disease type, the infectious disease diagnostics market is broadly segmented into hepatitis, human immunodeficiency virus (HIV), hospital-acquired infections (HAIs), human papillomavirus (HPV), tuberculosis (TB), influenza, and other diseases (measles, mumps, typhoid fever, malaria, meningitis, Ebola, and COVID-19, among others). In 2020, the hepatitis segment accounted for the largest share of the overall infectious disease diagnostics market. The large share of this segment is primarily attributed to the rising prevalence of hepatitis cases and increasing initiatives by government organizations towards hepatitis prevention.

Based on end user, the infectious disease diagnostics market is broadly segmented into hospital & clinical laboratories, diagnostic reference laboratories, academics/research institutes, and other end users (nursing facilities and home care facilities). In 2020, the diagnostic reference laboratories segment accounted for the largest share of the overall infectious disease diagnostics market. The large share of this segment is primarily attributed to the rising laboratory automation, availability of well-equipped systems, presence of skilled labors, rise in the number of the patient volume owing to the emergence of various infectious diseases, and government initiatives to support the technological advancements of laboratories.

Based on geography, the global infectious disease diagnostics market is categorized into five major regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with a further analysis of major countries in these regions. In 2020, North America accounted for the largest share of the global infectious disease diagnostics market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The growing healthcare sector, increasing healthcare expenditure, growing demand for point-of-care testing, and increase in the research and development coupled with the development of novel advanced technologies for diagnosis are the major factors driving the growth of the North American market.

Quick Buy Infectious Disease Diagnostics Market Research Report:https://www.meticulousresearch.com/Checkout/65879068

Some of the key players operating in the global infectious disease diagnostics market are Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMrieux S.A. (France), Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience Inc. (U.S.), and Quidel Corporation (U.S.) among others.

To gain more insights into the market with a detailed table of content and figures, click here:https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976

Scope of the Report:

Infectious Disease DiagnosticsMarket by Product & Solution

Infectious Disease DiagnosticsMarket by Technology

Infectious Disease DiagnosticsMarket by Disease Type

Infectious Disease DiagnosticsMarket by End User

Infectious Disease DiagnosticsMarket by Geography

DownloadFree Sample Report Now @https://www.meticulousresearch.com/download-sample-report/cp_id=4976

Amidst this crisis, Meticulous Researchis continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here-https://www.meticulousresearch.com/custom-research

Related Reports-

In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) - Global Forecast to 2027

https://www.meticulousresearch.com/product/in-vitro-diagnostic-reagents-market-5110

Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, Research Institutes) - Global Forecast to 2027

https://www.meticulousresearch.com/product/influenza-diagnostics-market-5099

Point of Care Molecular Diagnostics Market by Product and Solution (Assay, Analyzer, Software, Services), Technology (RT-qPCR, INAAT), Application (Respiratory Diseases, Hospital Acquired Infections, STD), and End User - Global Forecast to 2027

https://www.meticulousresearch.com/product/point-of-care-molecular-diagnostics-market-5081

COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025

https://www.meticulousresearch.com/product/COVID-19-impact-assessment-health-and-life-sciences-industry-5098

About Meticulous Research

Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact:

Mr.Khushal BombeMeticulous Market Research Inc.1267WillisSt,Ste200 Redding,California,96001, U.S.USA: +1-646-781-8004Europe : +44-203-868-8738APAC: +91 744-7780008Email-[emailprotected] Visit Our Website:https://www.meticulousresearch.com/ Connect with us on LinkedIn-https://www.linkedin.com/company/meticulous-research Content Source:https://www.meticulousresearch.com/pressrelease/55/infectious-disease-diagnostics-market-2027

SOURCE Meticulous Market Research Pvt. Ltd

Continue reading here:
Infectious Disease Diagnostics Market to Reach $42.85 Billion by 2027, Growing at a CAGR of 6.9% from 2020 with COVID-19 Impact - Meticulous Research...

Valo Health is a drug development company headquartered in Boston, Massachusetts, the United States, which uses human-centric data and machine learning to strengthen and boost the process of drug discovery and its development to promote intelligent health. The Opal Computational Platform by Valo Health utilizes the available clinical data and identifies the different molecules present to better the therapy results. This ensures that the procedure of drug discovery is an end-to-end process and can be used for an entire plethora of diseases. In the recent Series B funding rounds, this organization managed to add another $100 million in its funding, taking the total funding received in this round to $300 million. This funding will be primarily utilized for R&D to further improve technology and expand the drug development program.

This organization was formed in 2019 by David Berry under Flagship Pioneering, a Cambridge-based mega-giant already having companies like Moderna and Indigo Ag in its ambit. Valo Healths main aim is to use machine learning in a manner wherein previously unknown molecules associations can be identified and brought to light. The focus here is unlimited, and Valo Health claims that their products could be highly disruptive to the industry and bring in significant value so as to equip the people with better and enhanced treatment alternatives.

The entire process of drug discovery and development is being re-imagined by Valo Health. By using artificial intelligence and machine learning, the processs cost and time have been potentially cut in half. The technology at this organization blends in an enormous amount of human data with machine learning computation to allow itself to go from simply making molecules to then testing them in mere months. This allows medical chemistry optimization on a large scale.

Valo Health was formerly known as Integral Health, and it was launched after acquiring two firms, Forma Therapeutics, and Numerate which not only provided it with a sound capital from discoveries but also gave the essential asset in the form of engineers who had already created a base of 30,000 models and around 70 trillion molecules. The company unites human intelligence and machine intelligence to accelerate the entire process. It claims that it has been able to manufacture the first closed-loop, human-centric, activity learning, and end-to-end integrated drug discovery and development engine.

The company builds off the experience and products available from the other firms in the market and tries to look at it from a different perspective altogether, keeping an eye out for new opportunities to improve the same or even extend it further up a notch. The company, as of now, is focusing on advancing new medicines, refining its discovery and developmental engine, and coming up with new programs.

Source Link: https://www.valohealth.com/

Suggested

Visit link:
This Boston Based Startup is Applying Machine Learning-Anchored Computation to Enhance Drug Discovery and Development - MarkTechPost

DURHAM, N.C. -- Even if you cant name the tunes, youve probably heard them: from the iconic dun-dun-dun-dunnnn opening of Beethoven's Fifth Symphony to the melody of Ode to Joy, the German composers symphonies are some of the best known and widely performed in classical music.

Just as enthusiasts can recognize stylistic differences between one orchestras version of Beethovens hits and another, now machines can, too.

A Duke University team has developed a machine learning algorithm that listens to multiple performances of the same piece and can tell the difference between, say, the Berlin Philharmonic and the London Symphony Orchestra, based on subtle differences in how they interpret a score.

In a study published in a recent issue of the journal Annals of Applied Statistics, the team set the algorithm loose on all nine Beethoven symphonies as performed by 10 different orchestras over nearly eight decades, from a 1939 recording of the NBC Symphony Orchestra conducted by Arturo Toscanini, to Simon Rattles version with the Berlin Philharmonic in 2016.

Although each follows the same fixed score - the published reference left by Beethoven about how to play the notes -- every orchestra has a slightly different way of turning a score into sounds.

The bars, dots and squiggles on the page are mere clues, said Anna Yanchenko, a Ph.D. student and musician working with statistical science professor Peter Hoff at Duke. They tell the musicians what instruments should be playing and what notes they play, and whether to play slow or fast, soft or loud. But just how fast is fast? And how loud is loud?

Its up to the conductor -- and the individual musicians -- to bring the music to life; to determine exactly how much to speed up or slow down, how long to hold the notes, how much the volume should rise or fall over the course of a performance. For instance, if the score for a given piece says to play faster, one orchestra may double the tempo while another barely picks up the pace at all, Yanchenko said.

Hoff and Yanchenko converted each audio file into plots, called spectrograms and chromagrams, essentially showing how the notes an orchestra plays and their loudness vary over time. After aligning the plots, they calculated the timbre, tempo and volume changes for each movement, using new statistical methods they developed to look for consistent differences and similarities among orchestras in their playing.

Some of the results were expected. The 2012 Beethoven cycle with the Vienna Philharmonic, for example, has a strikingly similar sound to the Berlin Philharmonics 2016 version -- since the two orchestras were led by the same conductor.

But other findings were more surprising, such as the similarities between the symphonies conducted by Toscanini with regular modern instruments, and those played on period instruments more akin to Beethovens time.

The study also found that older recordings were more quirky and distinctive than newer ones, which tended to conform to more similar styles.

Yanchenko isnt using her code and mathematical models as a substitute for experiencing the music. On the contrary: shes a longtime concert-goer at the Boston Symphony Orchestra in her home state of Massachusetts. But she says her work helps her compare performance styles on a much larger scale than would be possible by ear alone.

Most previous AI efforts to look at how performance styles change across time and place have been limited to considering just a few pieces or instruments at a time. But the Duke teams method makes it possible to contrast many pieces involving scores of musicians and dozens of different instruments.

Rather than have people manually go through the audio and annotate it, the AI learns to spot patterns on its own and understands the special qualities of each orchestra automatically.

When shes not pursuing her Ph.D., Yanchenko plays trombone in Dukes Wind Symphony. Last semester, they celebrated Beethoven's 250th birthday pandemic-style with virtual performances of his symphonies in which all the musicians played their parts by video from home.

I listened to a lot of Beethoven during this project, Yanchenko said. Her favorite has to be his Symphony No. 7.

I really like the second movement, Yanchenko said. Some people take it very slow, and some people take it more quickly. It's interesting to see how different conductors can see the same piece of music.

The team's source code and data are available online at https://github.com/aky4wn/HMDS.

CITATION: "Hierarchical Multidimensional Scaling for the Comparison of Musical Performance Styles," Anna K. Yanchenko, Peter D. Hoff. Annals of Applied Statistics, December 2020. DOI: 10.1214/20-AOAS1391

Visit link:
Machine Learning Meets the Maestros | Duke Today - Duke Today

Machine learning is one of the most used technologies in this generation. It has varied capabilities that can transform businesses across industries for the better. From being considered as a niche technology, machine learning is now seeing an increased adoption within companies in all sectors.

From a global perspective, brands are leveraging machine learning to accelerate innovation and better customer experience. For example, Nike uses machine learning for personalized product recommendations. In the F&B industry, Dominos maintains its 10 minutes or less pizza delivery time using machine learning technologies. Another widely used example is how automobile giant BMW uses machine learning to analyze data from vehicle subsystems and predicts the performance of vehicle components and recommends when they should be serviced.

In 2020, machine learning became a priority for tech companies in order to achieve revenue growth while reducing costs. In 2021, those companies are now exploring many matured applications of this technology. Disruptive tech organizations have been leading this technology across many areas like process automation, customer experience, and security.

Following the continuing growth trend, these five industries are likely to adopt machine learning to change their business processes in 2021.

The coronavirus global pandemic has highlighted the importance of investing on and optimizing the healthcare systems. Machine learning is being considered as the most promising technology that enables healthcare providers to generate large volumes of data for insightful clinical decisions. Machine learning also enables huge processes in drug discovery, cutting down the long discovery and development time and reducing overall costs. It can also improve healthcare delivery systems to better the overall quality of healthcare under low costs. In the future, machine learning is predicted to be a critical part of clinical trials. Including pharmaceuticals and the biotech industry, machine learning will be having a huge impact in all aspects.

The banking sector is already seeing many advanced use cases of machine learning, especially when it comes to fraud detection and automating processes. Machine learning applications will be proactively explored in areas in trading, investment modeling, risk prevention, and customer sentiment analysis. As countries are making digital transactions their primary mode of payment, machine learning is combining predictive analytics to play a pivotal role in helping financial companies to improve transaction efficiencies within the entire transaction lifecycle. Banks and financial institutions will also use machine learning technology to customize their banking products and offerings to stay up to date in the competitive environment.

Media giants like Amazon and Netflix have already popularized the data-based content consumption channels in recent times. When the world got initially struck with the global pandemic, the demand for new consumption models grew and left companies to leverage their artificial intelligence and machine learning capabilities to create value for the customers. In this process, machine learning is going to be crucial for the media and entertainment industry , whether its developing better recommendation engines, delivering hyper-targeted services, or presenting the most relevant content in real-time. Predictive modeling will also be key in communicating with the customers on time, anticipating their future demands, and making good investments.

The retail industry saw a big shift owing to the coronavirus pandemic. The pandemic has disrupted many traditional practices of this industry and machine learning has become a key enabler of change. From the perspective of brick and mortar stores or e-commerce companies, machine learning is helping this sector reinvent their supply chain, inventory management, predicting user behaviour, and analyzing trends. Dynamic pricing is emerging as a key machine learning application to help retailers thrive in the competitive market.

IoT devices have already flooded this industry and it is only going to increase. Machine learning will be critical to bridge the gaps created by huge amounts of data. It will serve as a building block for the industry along with automation, data connectivity, real-time error detection, supply chain visibility, warehousing efficiency, cost reduction, and asset tracking. Keeping traditional processes aside, machine learning will facilitate innovation and efficiency in the coming days.

See more here:
In 2021, Machine Learning Is Set To Transform These 5 Industries - Analytics Insight